insights_auto
Why is ALNOV down 3,56%?
Dive Deeperchevron_right
ALNOV:EPA
Novacyt SA
0,43 €
arrow_downward
-3,56%(-0,016) 1D
17-ноя., 17:35:22 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,45 €
High
0,45 €
Low
0,43 €
Mkt. cap
31,92 млн
Avg. vol.
168,29 миң
Volume
9,06 миң
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 млн
No. of employees
228
Open
0,45 €
High
0,45 €
Low
0,43 €
Mkt. cap
31,92 млн
Avg. vol.
168,29 миң
Volume
9,06 миң
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 млн
No. of employees
228
News stories
From web sources and news partners
BigGo Finance
·
40 мүнөт мурун
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
TV News Check
·
1 саат мурун
Dow Drops 849, Nasdaq Sinks 181, S&P 500 Falls 76
Investing.com
·
1 саат мурун
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.64%
Traders Union
·
1 саат мурун
Ryan Detrick: Technology stocks outperformed S&P 500 while 75 stocks declined
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees228
Founded2006-ж., 3-июл.
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com